-
Mashup Score: 3
In honor of C. diff Awareness Month, the IDSA Foundation invites you to join a webinar that will provide the latest insights on recurrent Clostridioides difficile infection. This session will highlight real-world outcomes from newly approved gut microbial therapies and offer a comprehensive look at the ongoing challenges posed by C. diff, recognized as one of the top five most urgent public health threats. With nearly 500,000 cases annually in the U.S. and up to 29,000 associated deaths, rCDI poses a critical risk, particularly with recurrence rates reaching 30% after an initial infection. The widespread use of antibiotics further increases this risk. Our specialists will discuss the current landscape of C. diff infections and explore innovative approaches to reduce recurrence, focusing on the benefits of GMT. This webinar will offer the opportunity for health care professionals to further their understanding of the epidemiology, treatment advancements and patient care considerations s
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6
Join us as we celebrate Healthy Lung Month with a webinar as part of the Dr. John G. Bartlett Memorial Education Series. Hosted by the IDSA Foundation and Bronchiectasis and NTM 360, a division of the COPD Foundation, this webinar will explore the intricacies of nontuberculous mycobacterial lung disease, unraveling its profound ramifications for patients and explain effective diagnostic and treatment approaches. With a particular focus on the imperative of early diagnosis, this event will shed light on the need to manage NTM in a comprehensive manner. Moreover, attendees will gain valuable insights into the intricate interplay between NTM and bronchiectasis, further illuminating the landscape of lung health. Learning Objectives: • Examine the epidemiology of NTM lung disease, including its causes and prevalence, and identify the common pathogens associated with NTM; • Contrast NTM and bronchiectasis in terms of their pathophysiology and examine the underlying mechanisms linking NTM wit
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 6
Join us as we celebrate Healthy Lung Month with a webinar as part of the Dr. John G. Bartlett Memorial Education Series. Hosted by the IDSA Foundation and Bronchiectasis and NTM 360, a division of the COPD Foundation, this webinar will explore the intricacies of nontuberculous mycobacterial lung disease, unraveling its profound ramifications for patients and explain effective diagnostic and treatment approaches. With a particular focus on the imperative of early diagnosis, this event will shed light on the need to manage NTM in a comprehensive manner. Moreover, attendees will gain valuable insights into the intricate interplay between NTM and bronchiectasis, further illuminating the landscape of lung health. Learning Objectives: • Examine the epidemiology of NTM lung disease, including its causes and prevalence, and identify the common pathogens associated with NTM; • Contrast NTM and bronchiectasis in terms of their pathophysiology and examine the underlying mechanisms linking NTM wit
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 9
Join us for collaborative webinar with ESCMID, where we will explore critical updates on two important global health topics: Mpox and H5N1. Experts from ESCMID will provide a European perspective on the latest developments in Mpox, while we dive into key updates and challenges surrounding H5N1. The webinar will feature two presentations followed by a Q&A session, offering an opportunity for interactive discussions and expert insights. Don’t miss the chance to stay informed and engaged on these evolving global health issues. Time: 10am ET / 17:00 CET (Central European Time)
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 9
Join us for collaborative webinar with ESCMID, where we will explore critical updates on two important global health topics: Mpox and H5N1. Experts from ESCMID will provide a European perspective on the latest developments in Mpox, while we dive into key updates and challenges surrounding H5N1. The webinar will feature two presentations followed by a Q&A session, offering an opportunity for interactive discussions and expert insights. Don’t miss the chance to stay informed and engaged on these evolving global health issues. Time: 10am ET / 17:00 CET (Central European Time)
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 9
Join us for collaborative webinar with ESCMID, where we will explore critical updates on two important global health topics: Mpox and H5N1. Experts from ESCMID will provide a European perspective on the latest developments in Mpox, while we dive into key updates and challenges surrounding H5N1. The webinar will feature two presentations followed by a Q&A session, offering an opportunity for interactive discussions and expert insights. Don’t miss the chance to stay informed and engaged on these evolving global health issues. Time: 10am ET / 17:00 CET (Central European Time)
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 7
Join us for collaborative webinar with ESCMID, where we will explore critical updates on two important global health topics: Mpox and H5N1. Experts from ESCMID will provide a European perspective on the latest developments in Mpox, while we dive into key updates and challenges surrounding H5N1. The webinar will feature two presentations followed by a Q&A session, offering an opportunity for interactive discussions and expert insights. Don’t miss the chance to stay informed and engaged on these evolving global health issues. Time: 10am ET / 17:00 CET (Central European Time)
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 9
Date: Thursday, February 1 (4:00 p.m.-5:15 p.m. ET) (U.S. and Canada) Topic: Prevention & Treatment of Respiratory Tract Infections in Long-Term Care Facilities: Challenges & Solutions The agenda and details are below. 1. Introductions Moderator: • Dana S. Wollins, DrPH, MGC Vice President, Clinical Affairs & Practice Guidelines, IDSA 2. Topics i. Vaccination Uptake in Long-Term Care…
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 9
Date: Thursday, February 1 (4:00 p.m.-5:15 p.m. ET) (U.S. and Canada) Topic: Prevention & Treatment of Respiratory Tract Infections in Long-Term Care Facilities: Challenges & Solutions The agenda and details are below. 1. Introductions Moderator: • Dana S. Wollins, DrPH, MGC Vice President, Clinical Affairs & Practice Guidelines, IDSA 2. Topics i. Vaccination Uptake in Long-Term Care…
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
-
Mashup Score: 12
Join us Aug. 29 at 1 p.m. ET as we kick off the Dr. John G. Bartlett Memorial Education Series in 2024 with a webinar that explores the upcoming respiratory season. The webinar aims to address the combined impact of respiratory syncytial virus, influenza and COVID-19 by highlighting the effectiveness of vaccines in preventing severe illness. It will review the latest vaccination guidelines and recommendations for the 2024-2025 season and provide health care providers with strategies to facilitate informed patient discussions on immunization. Learning Objectives: • Explore previous vaccination rates and attitudes toward seasonal vaccines among diverse demographic groups and populations. • Summarize ACIP recommendations for vaccines against RSV, COVID-19 and influenza. • Determine the best vaccination approach using patient case studies. • Develop follow-up strategies to monitor patient responses to vaccinations. • Address recent challenges encountered in vaccine distribution and employ
Source: societycentral.zoom.usCategories: General Medicine News, Infectious DiseaseTweet
With nearly 500,000 cases annually in the U.S. recurrent C. diff poses a critical risk. Don’t miss our next webinar covering treatment advancements, the role of gut microbial therapies, and strategies to reduce recurrence. Register today ⬇️ 🔗 https://t.co/fzBES3beWk… https://t.co/IQvznEUIyN https://t.co/CH9bnEDq6B